Research datakeyboard_double_arrow_right Bioentity 25 Sep 2008Funded by:NHMRC | Molecular Regulation of B..., NHMRC | Independent MRI Infrastru..., NHMRC | SPRY domain-containing SO... +2 projects

Authors: 3 c. Bountra; S. Knapp; A. Bullock; Structural genomics consortium (sgc);

3emw

- Summary
- Related research
  (6)
- Metrics

tips_and_updates
Recommended

No summary information available

6 Research products, page 1 of 1

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

3emw

3emw

6 Research products, page 1 of 1

¹⁹F NMR viewed through two different lenses: ligand-observed and protein-observed¹⁹F NMR applications for fragment-based drug discovery

Crystal Structure-Based Exploration of Arginine-Containing Peptide Binding in the ADP-Ribosyltransferase Domain of the Type III Effector XopAI Protein

Crystal structure of the SPRY domain of human SPSB2 in the apo state

Structural Basis for Par-4 Recognition by the SPRY Domain- and SOCS Box-Containing Proteins SPSB1, SPSB2, and SPSB4

Structural Basis for Par-4 Recognition by the SPRY Domain- and SOCS Box-Containing Proteins SPSB1, SPSB2, and SPSB4

Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments

3emw

3emw

6 Research products, page 1 of 1

19F NMR viewed through two different lenses: ligand-observed and protein-observed19F NMR applications for fragment-based drug discovery

Crystal Structure-Based Exploration of Arginine-Containing Peptide Binding in the ADP-Ribosyltransferase Domain of the Type III Effector XopAI Protein

Crystal structure of the SPRY domain of human SPSB2 in the apo state

Structural Basis for Par-4 Recognition by the SPRY Domain- and SOCS Box-Containing Proteins SPSB1, SPSB2, and SPSB4

Structural Basis for Par-4 Recognition by the SPRY Domain- and SOCS Box-Containing Proteins SPSB1, SPSB2, and SPSB4

Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments

¹⁹F NMR viewed through two different lenses: ligand-observed and protein-observed¹⁹F NMR applications for fragment-based drug discovery